Increased our position in Inari Medical, Inc. due to attractive valuations for a market-leading medical device company. Inari dominates the PE market and has significant growth opportunities in both ...
Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on ...
IRVINE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients ...
Inari Medical, Inc.'s share price has dropped due to an investigation on doctor payment practices, creating a buying opportunity for risk-willing investors. Inari creates mechanical thrombectomy ...
Inari Medical is a medical device company. Bob Rosenbluth founded it in 2013. Inari develops products to treat venous diseases. Currently, the company offers two products, the ClotTriever and ...
Inari’s Defiance clinical trial is treating patients with deep vein thrombosis using its ClotTriever system Inari Medical Inc., which designs medical devices to remove large blood clots from veins, is ...
Inari Medical Inc., which began in 2011, tried to prove for years it’s pioneering a new way of treating patients with blood clots in their veins. Doctors nowadays are clearly impressed, having treated ...
Sorrento Therapeutics Inc. has divulged antibody-drug conjugates comprising antibodies targeting HER2 covalently linked to exatecan through a linker. They are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback